Cetera Investment Advisers Verona Pharma PLC Transaction History
Cetera Investment Advisers
- $45.9 Billion
- Q4 2024
A detailed history of Cetera Investment Advisers transactions in Verona Pharma PLC stock. As of the latest transaction made, Cetera Investment Advisers holds 23,265 shares of VRNA stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,265
Previous 10,903
113.38%
Holding current value
$1.58 Million
Previous $313,000
245.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VRNA
# of Institutions
218Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Perceptive Advisors LLC New York, NY6.39MShares$434 Million9.9% of portfolio
-
Nea Management Company, LLC Timonium, MD5.58MShares$380 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$230 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$213 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$213 Million2.81% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $4.14B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...